Search

Nearly 50,000 persons died of opioid overdoses in 2017, which contributed to the first-ever decline in working-age Americans’ life expectancy. A 2012 Abt Global study found wide geographic variation in opioid prescribing in the United States, indicating…

Misuse of opioid analgesics threatens public health and results in rising numbers of overdose deaths and admissions to emergency departments and treatment facilities. In the absence of adequate patient information systems, patients who engage in “doctor…

Our work has helped address the supply of and demand for illegal drugs and the misuse of legal substances for federal, state and local agencies, as well as other key stakeholders.

The Centers for Disease Control and Prevention (CDC) is charged with creating the expertise, information, and tools needed for health promotion, disease prevention, injury and disability, and preparedness. As a result, CDC needs partners poised to…

The misuse of opioids is a national crisis. One aspect of the larger problem relates to prescription opioids for Medicare beneficiaries. The Centers for Medicare & Medicaid Services (CMS) needs to evaluate trends to fight potential fraud, waste, and…

Following the COVID-19 pandemic and amid other virus outbreaks, the Centers for Disease Control and Prevention (CDC) learned many lessons and acquired deep expertise in how to communicate with the American public. CDC aims to take these lessons learned…

The Abt team supported the Centers for Disease Control and Prevention (CDC) in its effort to assess and address the educational needs of HCPs treating pediatric patients with suspected and confirmed cases of Multisystem Inflammatory Syndrome in Children …

Primary care practices need to redesign the way they provide care to balance preventing opioid misuse and potential risks while addressing the needs of patients with chronic pain. The Agency for Healthcare Research and Quality (AHRQ) awarded Abt a…